scispace - formally typeset
K

Kim Tieu

Researcher at Florida International University

Publications -  66
Citations -  11047

Kim Tieu is an academic researcher from Florida International University. The author has contributed to research in topics: Neurodegeneration & MPTP. The author has an hindex of 35, co-authored 50 publications receiving 9900 citations. Previous affiliations of Kim Tieu include Columbia University & University of Rochester.

Papers
More filters
Journal ArticleDOI

PINK1-dependent recruitment of Parkin to mitochondria in mitophagy

TL;DR: It is suggested that Parkin, together with PINK1, modulates mitochondrial trafficking, especially to the perinuclear region, a subcellular area associated with autophagy, which may alter mitochondrial turnover which, in turn, may cause the accumulation of defective mitochondria and, ultimately, neurodegeneration in Parkinson's disease.
Journal ArticleDOI

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

TL;DR: It is shown that minocycline, an approved tetracycline derivative that inhibits microglial activation independently of its antimicrobial properties, mitigates both the demise of nigrostriatal dopaminergic neurons and the formation of nitrotyrosine produced by MPTP.
Journal ArticleDOI

Glutathione dysregulation and the etiology and progression of human diseases.

TL;DR: The present report highlights and integrates the growing connections between imbalances in GSH homeostasis and a multitude of human diseases and suggests the high GSH content makes cancer cells chemoresistant, which is a major factor that limits drug treatment.
Journal ArticleDOI

Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture

TL;DR: Observations indicate that adenosine mediates the effects of acupuncture and that interfering withAdenosine metabolism may prolong the clinical benefit of acupuncture.
Journal ArticleDOI

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

TL;DR: It is demonstrated that targeting COX-2 does not protect against MPTP-induced dopaminergic neurodegeneration by mitigating inflammation, and evidence is provided that COx-2 inhibition prevents the formation of the oxidant species dopamine-quinone, which has been implicated in the pathogenesis of PD.